Author: Kaitlyn Short
Where most online weight-loss services stop at a prescription, welludr. builds its GLP-1 program around unlimited messaging with licensed clinicians. Welludr is a telehealth company that says its services are available in all 50 states to adults 18 and older, offering online weight-loss treatment with semaglutide and tirzepatide when a clinician decides it is appropriate.
The process starts with a short online assessment. A U.S.-licensed clinician, through OpenLoop Health or another clinical network, reviews the intake, makes every prescribing decision, and builds a personalized plan. Medication is then prepared by a licensed pharmacy and shipped every four weeks, with dosing adjusted as the patient responds.
Patients can message licensed clinicians as often as they need for dosing questions, tolerance, and side-effect support.
Welludr ships medication on a four-week cycle, timed so the next supply arrives before the current one runs out.
The online platform includes progress tracking and AI-assisted check-ins designed to support consistency between clinician contacts.
Welludr LLC provides technology and administrative support only. Diagnosis and prescribing belong to independent clinicians, and an assessment does not guarantee treatment.
When a clinician prescribes a compounded medication, the site states that it is not FDA-approved, is not a generic, and should not be assumed equivalent to a brand-name drug.
Adults who expect to have questions along the way, and who want a clinician on call by message rather than scheduled check-ins alone, are the audience welludr. is aiming for.
The way in is the three-minute eligibility quiz on the welludr. site; a licensed clinician then reviews your answers before any plan is set.
We're on a mission to empower consumers to make the best decisions and connect confidently with companies that deserve their business.
© 2026 BestCompany.com LLC - All rights reserved Privacy Policy | Terms | Do Not Sell My Personal Information